Sort
23,748 grants matching “melanoma”
Molecular Mechanisms of Metastasis Suppression by NM23
$203,946David M Kaetzel · University Of Kentucky · R01 · FY2010 · CA
Molecular Mechanisms of Metastasis Suppression by NM23
$203,946David M Kaetzel · University Of Kentucky · R01 · FY2008 · CA
Prostate Cancer and Obesogenic Factors
$203,914Everardo Macias · Cedars-Sinai Medical Center · R21 · FY2017 · CA
CORE 3: Bioinformatics
$203,871Ivan P Gorlov · University Of New Mexico Health Scis Ctr · P01 · FY2017 · CA
Project 2 - Joshua Hood, PhD
$203,853Joshua L. Hood · University Of Louisville · P20 · FY2024 · GM
Feasibility Study To Prevent Post-ICU Depression
$203,850Craig R Weinert · University Of Minnesota · R34 · FY2008 · MH
Feasibility Study To Prevent Post-ICU Depression
$203,850Craig R Weinert · University Of Minnesota · R34 · FY2009 · MH
Feasibility Study To Prevent Post-ICU Depression
$203,850Craig R Weinert · University Of Minnesota · R34 · FY2010 · MH
Cancer Pharmacokinetics and Pharmacodynamics Facility
$203,836Jan Hendrik Beumer · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
Precision Tumor Sampling of Melanoma Using Laser Microbiopsy
$203,610Sapun H Parekh · University Of Texas At Austin · R61 · FY2024 · CA
ROLE OF HLA ALLELES AND CYTOKINES IN MELANOMA PROGNOSIS
$203,600Jeffrey E Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2008 · CA
(PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to Therapy
$203,580Michael A Teitell · University Of California Los Angeles · R21 · FY2020 · CA
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
$203,580Sapna Patel · University Of Tx Md Anderson Can Ctr · R21 · FY2016 · CA
Targeting tissue factor as a novel oncotarget for immunotherapy of triple negative breast cancer
$203,580Zhiwei Hu · Ohio State University · R21 · FY2018 · CA
Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome
$203,471Mohamed H. Abdel-Rahman · Ohio State University · R21 · FY2018 · CA
Development of a new treatment modality for melanoma brain metastases - Resubmission - 1
$203,400Iman Osman · New York University School Of Medicine · R21 · FY2015 · CA
Regulation of TRAF2 Activity in Normal and Tumor Cells
$203,376Hasem Habelhah · University Of Iowa · R01 · FY2007 · CA
Regulation of TRAF2 Activity in Normal and Tumor Cells
$203,376Hasem Habelhah · University Of Iowa · R01 · FY2008 · CA
Regulation of TRAF2 Activity in Normal and Tumor Cells
$203,376Hasem Habelhah · University Of Iowa · R01 · FY2009 · CA
ON THE ROLE OF THE HPS GENE PRODUCT IN MELANOCYTES
$203,372University Of Cincinnati · R01 · FY2000 · AR
Role of probiotic Lactobacillus reuteri in orchestrating systemic anti-tumor immunity
$203,352Marlies Meisel · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · CA
Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer
$203,337Samuel I Gunderson · Rutgers, The State Univ Of N.J. · R21 · FY2015 · CA
Using a Narrative-Based Approach to Reducing Indoor Tanning
$203,326Sherry L Pagoto · University Of Connecticut Storrs · R21 · FY2019 · CA
UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP
$203,295University Of Colorado Denver · U10 · FY2003 · CA
Slug Mediates the Acute Cutaneous Response to UVR
$203,280Donna F Kusewitt · University Of Tx Md Anderson Can Ctr · R21 · FY2009 · AR